Minnesota SF1739 establishes a prior authorization commission to review and recommend medications for prohibition from prior authorization.

Minnesota SF1739 creates a prior authorization commission to analyze and recommend medications for prohibition from prior authorization. The commission will review the 25 medications with the highest prior authorization denial rates and base its recommendations on criteria including cost, utilization, coverage, effectiveness, and medical necessity. The commissioner of health must approve one medication annually for inclusion in the prohibition. The bill also mandates annual reports from the commission and allows certain data sharing for analysis purposes.

Minnesota SF1739 establishes a prior authorization commission to review and recommend medications for prohibition from prior authorization.

Minnesota SF1739 creates a prior authorization commission to analyze and recommend medications for prohibition from prior authorization. The commission will review the 25 medications with the highest prior authorization denial rates and base its recommendations on criteria including cost, utilization, coverage, effectiveness, and medical necessity. The commissioner of health must approve one medication annually for inclusion in the prohibition. The bill also mandates annual reports from the commission and allows certain data sharing for analysis purposes.